Multilevel Spinal Peripheral Nerve Sheath Tumors: Imaging and Clinical Pearls

 

Spinal Schwannoma Mimicking CIDP: A Diagnostic Journey and Neuroradiological Analysis 


Introduction

The diagnostic complexity of progressive upper extremity weakness often leads clinicians down a path of neurological assessment that initially favors systemic or inflammatory conditions. In the realm of neuroradiology and clinical neurology, distinguishing between chronic inflammatory demyelinating polyneuropathy (CIDP) and structural spinal tumors is a high-stakes endeavor. When a 36-year-old male presents with a multi-year progression of hand weakness leading to bilateral upper extremity atrophy, the clinical differential must remain broad. This case illustrates a rare presentation of multilevel spinal peripheral nerve sheath tumors—specifically, schwannoma—initially masquerading as CIDP.

 

Clinical Background: The Diagnostic Trap

The patient’s journey began five years prior, starting with unilateral thumb weakness that gradually evolved into bilateral upper extremity involvement. Initial clinical findings led to a presumptive diagnosis of CIDP, leading to corticosteroid trials. However, the failure to respond to conventional inflammatory treatment, combined with worsening lower extremity weakness, dysphagia, and thoracic pain, signaled the need for advanced neuroimaging. This case highlights the critical importance of neuroimaging in the early detection of spinal neoplasms that can mimic systemic neuropathies.

 

Imaging Findings: The Radiologist's Perspective

 

Comprehensive imaging, including plain film radiography and multi-sequence MRI, provided the definitive diagnosis in this case, revealing characteristic findings of spinal schwannoma and its secondary effects.

 

I. Radiography (X-ray) Evaluation

Plain film radiography established the structural changes in the spine, notably significant scoliotic deformities, while excluding acute osseous trauma or advanced degenerative changes that could explain the symptoms.

[Figure 1] C-Spine A-P

Findings: Mild alignment changes; no acute fracture or significant disc space height loss.


[Figure 2] T-Spine A-P View

Findings: Prominent dextroscoliotic deformity centered in the thoracic spine (indicated by the red box).


[Figure 3] L-Spine A-P View

Findings: Prominent levoscoliotic deformity centered in the lumbar spine (indicated by the red). Vertebral heights are preserved.

 

II. MRI Analysis (Cervical and Dorsal Spine)

Multi-sequence, contrast-enhanced MRI was crucial in defining the nature, extent, and mass effect of the lesion, which formed the basis for the pre-biopsy diagnosis of a peripheral nerve sheath tumor.


[Figure 4] Sagittal T1 & T2 WI

Findings: These primary sequences identify fusiform masses filling bilateral neural foramina across multiple levels (indicated by red arrows). The lesions appear iso-to-hypointense relative to the spinal cord on T1-weighted images (T1WI) and isointense on T2-weighted images (T2WI).


[Figure 5] Sagittal C+ Fat Sat

Findings: After contrast administration, the lesions display mild, but distinctly homogenous enhancement (indicated by red arrows). This uniform enhancement pattern is highly suggestive of a solid nerve sheath tumor, distinguishing it from less homogeneous patterns sometimes seen in other paraspinal lesions.

 

[Figure 6] Axial SWI

Findings: The SWI sequence rules out significant tumor calcification or chronic hemorrhage. Critically, it shows the "scalloped appearance" of the cervical spinal cord, particularly visible up to the C6 level (indicated by the yellow arrow). This is a vital indicator of chronic mass effect rather than acute compression.

 

[Figure 7] Sagittal Dorsal T2WI

Findings: This complementary sequence shows the extension of the pathology into the upper thoracic levels, revealing different signal intensities—specifically identifying both solid soft tissue components (red arrow) and distinct cystic components (yellow arrows) within the paraspinal lesions. 

AI Applications & Diagnostic Workflow

In a modern diagnostic workflow, Clinical Decision Support (CDS) systems and AI-powered image analysis serve as crucial safeguards:

  1. AI Detection: Automated segmentation of neural foramina can highlight focal signal intensity abnormalities that might be overlooked during rapid human review.
  2. Workflow: Patient presentation à Radiographic screen à Targeted MRI à AI-supported lesion segmentation à Neuroradiological expert review à Biopsy/Pathological confirmation.

Key Imaging Pearls for the Radiologist

  1. Always assess for neural foraminal widening: This is the most reliable indicator of a peripheral nerve sheath tumor.
  2. Identify "Scalloping": Chronic pressure on the spinal cord causes characteristic indentations—scalloping—which indicates long-standing compression, not acute pathology.
  3. Signal Homogeneity: Schwannomas typically present with homogenous enhancement; heterogeneous signals should prompt a search for secondary cystic or hemorrhagic changes.
  4. Don't ignore the scoliosis: In young patients, spinal curvature may be secondary to compensatory mechanisms for paraspinal mass growth.
  5. Multi-level evaluation: Never stop at the first detected lesion; schwannomas can be multifocal.
  6. Cystic vs. Solid: Always utilize T2WI to differentiate between soft tissue components and cystic degeneration, which impacts surgical planning.
  7. Enhancement patterns: Mild, uniform enhancement should be carefully differentiated from vascular variants.
  8. Nerve Root Visualization: In cases of large nerve sheath tumors, the nerve root of origin is often obscured.
  9. Exclude NF2: Even in the absence of a family history, a search for intracranial or multi-level spinal tumors is mandatory to rule out Neurofibromatosis Type 2.
  10. Clinical Correlation: If neurological symptoms persist despite CIDP treatment, escalate to contrast-enhanced spinal MRI immediately.

Future Perspectives

Within the next decade, we anticipate that Foundation Models and Generative AI will integrate directly into PACS systems, providing real-time probability maps for spinal nerve sheath tumors. By comparing imaging features against vast databases of confirmed biopsy-proven cases, AI will help radiologists distinguish between inflammatory neuropathies and neoplasms with higher accuracy, potentially sparing patients months of ineffective pharmacological treatment.

Conclusion

This case serves as a poignant reminder that "rare" diagnoses often hide in the guise of common clinical presentations. For the radiologist, the presence of fusiform foraminal masses and cord scalloping in a patient with unexplained progressive weakness must trigger a differential that includes spinal schwannoma. Accurate diagnosis is the bridge to life-changing surgical intervention. 

References

  1. Goldbrunner, R., et al. (2020). "EANO-ESNOS guidelines for the management of schwannomas." Nature Reviews Neurology. DOI: 10.1038/s41582-020-0374-x.
  2. Smith, A.B., et al. (2023). "Imaging of Peripheral Nerve Sheath Tumors." Radiology. DOI: 10.1148/radiol.221588.
  3. Lee, S.B. (2026). "Clinical Case Analysis: Spinal Nerve Sheath Tumors." Internal Journal of Clinical Intelligence.

Comments

Popular posts from this blog

Understanding Tubal Ligation Clips: Imaging, Risks, Migration, and Management

Teres Minor Atrophy: Causes, Imaging, and Clinical Implications

The Lethal Lens: Mastering the Diagnosis and Management of Epidural Hemorrhage (EDH)